Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: gemcitabine|DRUG: paclitaxel
Sponsor: Eli Lilly and Company